Resistant Hypertension in Chronic Kidney Disease by Adrian Covic Mehmet Kanbay & Edgar V. Lerma

Author:Adrian Covic, Mehmet Kanbay & Edgar V. Lerma
Language: eng
Format: epub
Publisher: Springer International Publishing, Cham

Salt and Hypertension in CKD

Evidence shows that almost all CKD patients are salt sensitive; in these patients, high salt intake is linked to risk factors for both heart disease and worsening kidney function, including high BP, excess proteinuria, and fluid overload. The effect of sodium intake on BP is traditionally thought to be driven primarily through changes in fluid volume, mediated by the renin-angiotensin-aldosterone system (RAAS) , although recent research indicates that other mediators, like vascular stiffness or inflammation , may play an important role.

High sodium intake is thought to have direct toxic effects on blood vessels through mediating factors such as oxidative stress, inflammation, endothelial cell dysfunction, and vascular stiffness. High sodium intake enhances the generation of superoxide anion accompanied by enhanced renal expression and nicotinamide dehydrogenase activation. In addition, dietary salt increases the glomerular expression of TGF-β1 on renal tissue and also augments nitric oxide production. High salt intake also induces the intrarenal aldosterone receptor and promotes renal fibrotic injury ; it might also determine tissue inflammation by triggering IL-17-producing CD4+ T cell development [23].

Moreover, the excess sodium intake abrogates the antiproteinuric effects of angiotensin converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARBs) , thereby exacerbating proteinuria. Sodium restriction amplifies the top of the dose response of RAAS-blockade for both blood pressure and proteinuria. The effect of moderate sodium restriction during RAAS-blockade on blood pressure and proteinuria is almost similar to the effect of adding a diuretic. In a recent systematic review and meta-analysis, including 11 studies and 516 participants, sodium intake reduction markedly reduces albumin excretion, more so during concomitant RAAS-blocking therapy and among patients with kidney damage. An average reduction in sodium intake of 92 mmol/d was associated with a 32.1% reduction in urinary albumin excretion. A greater reduction of urinary albumin excretion was associated with a higher decrease in BP during the intervention [24].

There were several short-term studies on the effect of restricting salt intake on BP levels in CKD patients. In a small prospective trial of patients with CKD, McMahon and colleagues determined that a low-sodium diet (60–80 mmol/d) resulted in a reduction of 10 mmHg systolic pressure compared with a high-sodium diet. The authors also demonstrated that the low-sodium diet in this trial reduced protein excretion by more than 300 mg/d and also the extracellular volume [25, 26]. In a recent Cochrane meta-analysis including 8 studies and 258 people (with early-stage CKD, renal transplantation, one study, and peritoneal dialysis, one study), reduced sodium intake significantly reduced BP and antihypertensive medication dosage [27]. However, the authors found a critical evidence gap in long-term effects of salt restriction in people with CKD; they were unable to determine the direct effects of sodium restriction on primary endpoints such as mortality and progression to ESRD.

Download

Copyright Disclaimer:
This site does not store any files on its server. We only index and link to content provided by other sites. Please contact the content providers to delete copyright contents if any and email us, we'll remove relevant links or contents immediately.